ATE189460T1 - Gegen protozoen wirksamezyklische tetrapeptide - Google Patents
Gegen protozoen wirksamezyklische tetrapeptideInfo
- Publication number
- ATE189460T1 ATE189460T1 AT95928135T AT95928135T ATE189460T1 AT E189460 T1 ATE189460 T1 AT E189460T1 AT 95928135 T AT95928135 T AT 95928135T AT 95928135 T AT95928135 T AT 95928135T AT E189460 T1 ATE189460 T1 AT E189460T1
- Authority
- AT
- Austria
- Prior art keywords
- effective against
- cyclic tetrapeptides
- against protozoa
- tetrapeptides
- protozoa
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/14—Fungi; Culture media therefor
- C12N1/145—Fungal isolates
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/12—Cyclic peptides with only normal peptide bonds in the ring
- C07K5/126—Tetrapeptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/645—Fungi ; Processes using fungi
- C12R2001/77—Fusarium
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Veterinary Medicine (AREA)
- Tropical Medicine & Parasitology (AREA)
- Virology (AREA)
- General Engineering & Computer Science (AREA)
- Mycology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Biomedical Technology (AREA)
- Pharmacology & Pharmacy (AREA)
- Microbiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Botany (AREA)
- Biophysics (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Hydrogenated Pyridines (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US28132594A | 1994-07-27 | 1994-07-27 | |
US08/447,664 US5620953A (en) | 1994-07-27 | 1995-05-23 | Antiprotozoal cyclic tetrapeptides |
PCT/US1995/009371 WO1996003428A1 (en) | 1994-07-27 | 1995-07-24 | Antiprotozoal cyclic tetrapeptides |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE189460T1 true ATE189460T1 (de) | 2000-02-15 |
Family
ID=26960833
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT95928135T ATE189460T1 (de) | 1994-07-27 | 1995-07-24 | Gegen protozoen wirksamezyklische tetrapeptide |
Country Status (9)
Country | Link |
---|---|
US (2) | US5620953A (de) |
EP (1) | EP0777683B1 (de) |
JP (1) | JPH10503368A (de) |
AT (1) | ATE189460T1 (de) |
AU (1) | AU687602B2 (de) |
CA (1) | CA2194999A1 (de) |
CY (1) | CY2183B1 (de) |
DE (1) | DE69514928T2 (de) |
WO (1) | WO1996003428A1 (de) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5620953A (en) * | 1994-07-27 | 1997-04-15 | Merck & Co., Inc. | Antiprotozoal cyclic tetrapeptides |
US5922837A (en) * | 1995-09-20 | 1999-07-13 | Merck & Co., Inc. | Antiprotozoal cyclic tetrapeptides |
US6110697A (en) * | 1995-09-20 | 2000-08-29 | Merck & Co., Inc. | Histone deacetylase as target for antiprotozoal agents |
GB9903087D0 (en) * | 1999-02-12 | 1999-03-31 | Glaxo Group Ltd | Process |
JP2003505417A (ja) * | 1999-07-23 | 2003-02-12 | メルク エンド カムパニー インコーポレーテッド | アピシジン誘導環状テトラペプチド類 |
WO2002088298A1 (en) * | 2001-04-27 | 2002-11-07 | The Procter & Gamble Company | Compounds, compositions, and methods for controlling biofilms |
EP3461480A1 (de) | 2017-09-27 | 2019-04-03 | Onxeo | Kombination von checkpoint-hemmern des dna-schädigungsantwort-zellzyklus und belinostat zur behandlung von krebs |
EP3461488A1 (de) | 2017-09-27 | 2019-04-03 | Onxeo | Kombination aus einem dbait-molekül und einem hdac-inhibitor zur behandlung von krebs |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2410658A1 (fr) * | 1977-11-30 | 1979-06-29 | Science Union & Cie | Nouveau produit biologique d'origine fongique, son obtention et son application a la therapeutique |
US4338303A (en) * | 1980-02-04 | 1982-07-06 | Albert Einstein College Of Medicine Of Yeshiva University | Treatment of parasitic diseases |
FR2503182A1 (fr) * | 1981-04-07 | 1982-10-08 | Biofarma Sa | Nouvelle souche de fusarium utilisable pour la production d'antibiotiques |
JPH0334991A (ja) * | 1989-06-30 | 1991-02-14 | Shionogi & Co Ltd | 環状テトラペプチドおよびその製造法 |
CA2032559C (en) * | 1989-12-28 | 2001-11-06 | Kiyofumi Ishikawa | Endothelin antagonistic cyclic pentapeptides |
US5049546A (en) * | 1990-03-19 | 1991-09-17 | Merck & Co., Inc. | Antibiotic agents |
US5369093A (en) * | 1991-03-15 | 1994-11-29 | Merck & Co., Inc. | Lipopeptide derivatives |
DK0537418T3 (da) * | 1991-07-01 | 1998-10-12 | Ahc Inc | Hidtil ukendt bacillusbakterie og anvendelse heraf |
US5300491A (en) * | 1991-10-31 | 1994-04-05 | Apothekernes Laboratorium A.S. | Treatment of protozoal infection |
US5620953A (en) * | 1994-07-27 | 1997-04-15 | Merck & Co., Inc. | Antiprotozoal cyclic tetrapeptides |
-
1995
- 1995-05-23 US US08/447,664 patent/US5620953A/en not_active Expired - Fee Related
- 1995-07-24 AU AU32004/95A patent/AU687602B2/en not_active Ceased
- 1995-07-24 AT AT95928135T patent/ATE189460T1/de not_active IP Right Cessation
- 1995-07-24 CA CA002194999A patent/CA2194999A1/en not_active Abandoned
- 1995-07-24 JP JP8505930A patent/JPH10503368A/ja not_active Withdrawn
- 1995-07-24 WO PCT/US1995/009371 patent/WO1996003428A1/en active IP Right Grant
- 1995-07-24 EP EP95928135A patent/EP0777683B1/de not_active Expired - Lifetime
- 1995-07-24 DE DE69514928T patent/DE69514928T2/de not_active Expired - Fee Related
-
1997
- 1997-01-28 US US08/789,931 patent/US5861375A/en not_active Expired - Fee Related
-
2000
- 2000-08-23 CY CY0000043A patent/CY2183B1/xx unknown
Also Published As
Publication number | Publication date |
---|---|
CA2194999A1 (en) | 1996-02-08 |
CY2183B1 (en) | 2002-08-23 |
JPH10503368A (ja) | 1998-03-31 |
AU3200495A (en) | 1996-02-22 |
US5620953A (en) | 1997-04-15 |
DE69514928D1 (de) | 2000-03-09 |
WO1996003428A1 (en) | 1996-02-08 |
AU687602B2 (en) | 1998-02-26 |
EP0777683A1 (de) | 1997-06-11 |
DE69514928T2 (de) | 2000-08-17 |
EP0777683B1 (de) | 2000-02-02 |
US5861375A (en) | 1999-01-19 |
EP0777683A4 (de) | 1997-08-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20003233D0 (no) | 4-hydrokykinolin-3-karboksamider og hydraziner som antivirale midler | |
DK0705100T3 (da) | Terapeutiske substituerede guanidiner | |
NO982310L (no) | Protegriner | |
DE69925256D1 (de) | Trisubstituierte 1,3,5-triazine derivate zur behandlung von hiv infektionen | |
DE69739758D1 (de) | Vakzine zur behandlung von lymphomen und leukämie | |
ATE298741T1 (de) | Polyaromatische verbindungen zur behandlung von herpes-infektionen | |
DK0951473T3 (da) | Cyclosporinderivat, fremstilling af dette og farmaceutiske præparater indeholdende dette | |
CY1107439T1 (el) | Μεθοδοι προληψης και θεραπειας μολυνσης απο ιο του γενους flavivirus σε ζωα | |
ATE253351T1 (de) | Desodoriende zubereitungen enthaltend wasserlösliche -(1,3)-glucane | |
DE69533704D1 (de) | Bradykinin-antagonist peptide mit n-substituierten glycinen | |
DE69835536D1 (de) | Zusammensetzungen zur behandlung von staphylococcus aureus infektionen | |
ATE189460T1 (de) | Gegen protozoen wirksamezyklische tetrapeptide | |
ES2159287T3 (es) | Peptidos hemorreguladores. | |
ES2189206T3 (es) | Beta-alcoxiacrilatos contra la malaria. | |
DE69926485D1 (de) | Behandlung von durchblasgasen | |
NO20005548L (no) | Mykobakterieinhibitorer | |
DK120892D0 (da) | Treatment and prophylaxis of diseases caused by parasites, fungi or bacteria | |
ATA93695A (de) | Mittel zur behandlung von strahlenschäden | |
NO982151L (no) | Hemoregulatoriske forbindelser | |
ATE459372T1 (de) | Vorbeugung und behandlung von p. gingivalis infektion | |
KR940026235U (ko) | 오존을 이용한 마이크 살균소독기 | |
DK1133297T3 (da) | Ny terapeutisk anvendelse af 1,6-dimethyl-8beta-hydroxymethyl-10alpha-methoxyergolin |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |